EN
抗体药类似物
Research Grade Raxibacumab
All
TD-JN898026_1.jpg
  • CatalogTD-JN898026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsCAS:565451-13-0
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Raxibacumab


Catalog No. TD-JN898026
Species reactivity Bacillus anthracis
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-lambda
Expression system Mammalian Cells
Clonality Monoclonal
Target Protective antigen, PA, Anthrax toxins translocating protein, PA-83, PA83, Protective antigen PA-20, PA-20, PA20, Protective antigen PA-63, PA-63, PA63, pagA, pag, pXO1-110, BXA0164, GBAA_pXO1_0164
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P13423
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names CAS:565451-13-0
Background Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-JN898026_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Raxibacumab.